For research use only. Not for therapeutic Use.
Lobeglitazone sulfate is a thiazolidinedione (TZD) class drug that acts as a potent agonist of peroxisome proliferator-activated receptor gamma (PPAR-γ), primarily used in diabetes research. By activating PPAR-γ, lobeglitazone sulfate enhances insulin sensitivity and regulates glucose and lipid metabolism. It is used to manage type 2 diabetes by improving glycemic control and reducing insulin resistance. Additionally, it has shown potential in improving lipid profiles and reducing inflammation. Lobeglitazone sulfate is studied for its efficacy in metabolic disorders, making it a promising candidate for diabetes and related cardiovascular complications.
| Catalog Number | I007681 |
| CAS Number | 763108-62-9 (Sulfate) |
| Synonyms | CKD-501; CKD 501; CKD501; Lobeglitazone Sulfate. trade name Duvie, Chong Kun Dang.;5-(4-(2-((6-(4-methoxyphenoxy)pyrimidin-4-yl)(methyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione sulfate |
| Molecular Formula | C24H26N4O9S2 |
| Purity | ≥95% |
| Solubility | Soluble in DMSO |
| Storage | 0 - 4°C for short term , or -20°C for long term. |
| SMILES | O=C(N1)SC(CC2=CC=C(OCCN(C3=NC=NC(OC4=CC=C(OC)C=C4)=C3)C)C=C2)C1=O.O=S(O)(O)=O |
